BILIARY TRACT CANCER (BTC)
Clinical trials for BILIARY TRACT CANCER (BTC) explained in plain language.
Never miss a new study
Get alerted when new BILIARY TRACT CANCER (BTC) trials appear
Sign up with your email to follow new studies for BILIARY TRACT CANCER (BTC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for tough bile duct cancer
Disease control OngoingThis Phase 2 trial is testing a combination of paclitaxel polymer micelle and immunotherapy for people with advanced biliary tract cancer whose disease has progressed after standard first-line treatment. The study aims to see if this new drug combo can shrink tumors and control t…
Matched conditions: BILIARY TRACT CANCER (BTC)
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Taiwan launches genetic map for bile duct cancer
Knowledge-focused OngoingThis study collects tumor tissue from 480 people with advanced biliary tract cancer in Taiwan to analyze their genetic makeup. The goal is to create a detailed map of genetic changes in this cancer, which could help identify potential targeted therapies. Participants are already …
Matched conditions: BILIARY TRACT CANCER (BTC)
Sponsor: National Health Research Institutes, Taiwan • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC